Mainz Biomed N.V. Ordinary Shares

QUCYNASDAQUSD
0.48 USD
0.02 (3.71%)AT CLOSE (11:59 AM EDT)
0.49
0.00 (0.02%)
POST MARKET (AS OF 04:11 PM EDT)
Post Market
AS OF 04:11 PM EDT
0.49
0.00 (0.02%)
🟢Market: OPEN
Open?$0.46
High?$0.50
Low?$0.46
Prev. Close?$0.46
Volume?106.0K
Avg. Volume?N/A
VWAP?$0.48
Bid / Ask
Bid?$0.45 × 200
Ask?$0.50 × 200
Spread?$0.05
Midpoint?$0.48
Valuation & Ratios
Market Cap?5.7M
Shares Out?12.5M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
Employees
26
Market Cap
5.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-11-05
Address
ROBERT KOCH STRASSE 50
MAINZ, 2M 55129
Phone: 49 6131 5542860